In fiscal year 2025, S.Biomedics (304360) reported revenue of 16.5 billion KRW.
Income Statement
| Year | Revenue | Op Profit | Net Income | Source |
|---|---|---|---|---|
| 2025 | 16.5 billion KRW | -8.3 billion KRW | — | [source] |
| 2024 | 13.7 billion KRW | -5.4 billion KRW | -5.8 billion KRW | [source] |
| 2023 | 13.1 billion KRW | -6.0 billion KRW | -9.3 billion KRW | [source] |
| 2022 | 12.1 billion KRW | -3.7 billion KRW | -4.8 billion KRW | — |
| 2021 | 8.9 billion KRW | -4.6 billion KRW | — | — |
Balance Sheet
| Year | Total Assets | Total Liabilities | Total Equity | Source |
|---|---|---|---|---|
| 2025 | 23.3 billion KRW | 14.6 billion KRW | 8.7 billion KRW | [source] |
| 2024 | 28.6 billion KRW | 16.7 billion KRW | 11.9 billion KRW | [source] |
| 2023 | 15.1 billion KRW | 9.5 billion KRW | 5.6 billion KRW | [source] |
| 2022 | — | — | — | — |
| 2021 | — | — | — | — |
Figures for the relevant year were not collected.
Years without a source link are outside the DART financial API collection period.
Balance sheet figures for the relevant year were not collected.